AEA new tuberculosis blood test, developed by researchers led by Dr. Sheng-Wei Pan, could significantly improve early detection of the disease, potentially saving millions of lives. Tuberculosis (TB) remains a major global health issue, causing around 1.23 million deaths in 2024 and infecting approximately 10.7 million people worldwide. Current diagnostic methods rely on sputum samples, which can be unreliable for some patients. The new test uses a highly sensitive biosensor to detect a specific blood marker (ESAT-6) produced by the TB bacteria, allowing for more accurate differentiation between active and latent infections. While preliminary results show promise, the researchers emphasize the need for further studies to validate its effectiveness in real-world settings.
Bias read (Center): The article presents scientific findings without overt ideological framing. It focuses on medical advancements and public health implications rather than political agendas. While the potential impact of the test on global health is discussed, there is no evident slant toward any particular political
